The prognostic impact of NKA dynamics in first-line treatment of metastatic colorectal cancer

被引：0
|
作者：
Nederby, Line
Raunkilde, Louise
Jakobsen, Anders
Jensen, Lars Henrik
Havelund, Birgitte Mayland
Wen, Sara Witting Christensen
Hansen, Torben
机构：
[1] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Biochem & Immunol, Vejle, Denmark
[2] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[3] Univ Hosp Southern Denmark, Inst Reg Hlth Res, Vejle Hosp, Dept Oncol, Vejle, Denmark
[4] Univ Hosp Southern Denmark, Vejle Hosp, Danish Colorectal Canc Ctr South, Vejle, Denmark
[5] Univ Hosp Southern Denmark, Vejle Hosp, Dept Oncol, Vejle, Denmark
[6] Univ Southern Denmark, Inst Reg Hlth Res, Danish Colorectal Canc Ctr South, Dept Oncol,Vejle Hosp, Vejle, Denmark
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15514
引用
收藏
页数：1
相关论文
共 50 条
  • [21] First-Line Therapeutic Strategies in Metastatic Colorectal Cancer
    Davies, Janine M.
    Goldberg, Richard M.
    ONCOLOGY-NEW YORK, 2008, 22 (13): : 1470 - 1479
  • [22] Optimizing first-line chemotherapy for metastatic colorectal cancer
    Adams, Richard A.
    COLORECTAL CANCER, 2012, 1 (03) : 241 - 253
  • [23] Frequency of Body Weight Loss is an Independent Prognostic Factor of First-Line Treatment Outcomes in Metastatic Colorectal Cancer
    Prejac, Juraj
    Kekez, Domina
    Belev, Borislav
    Prejac, Marija
    Plestina, Stjepko
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (02): : 520 - 526
  • [24] Prognostic value of incidental betablockers use in metastatic colorectal cancer patients receiving first-line treatment: An update
    Del Prete, M.
    Giampieri, R.
    Scartozzi, M.
    Faloppi, L.
    Bianconi, M.
    Bittoni, A.
    Cascinu, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S569 - S570
  • [25] FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer
    Koca, Dogan
    Unal, Olcun Umit
    Oztop, Ilhan
    Yilmaz, Ugur
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 (02): : 198 - 204
  • [26] CETUXIMAB IN COMBINATION WITH XELIRI OR XELOX IN FIRST-LINE TREATMENT OF METASTATIC COLORECTAL CANCER
    Ocvirk, Janja
    Rebersek, Martina
    Boc, Marko
    Mesti, Tanja
    Moltara, Maja Ebert
    ANNALS OF ONCOLOGY, 2011, 22 : v96 - v96
  • [27] ctDNA variations according to treatment intensity in first-line metastatic colorectal cancer
    Grancher, Adrien
    Beaussire-Trouvay, Ludivine
    Vernon, Virginie
    Dutherage, Marie
    Blondin, Valerie
    Elie, Caroline
    Bouhier-Leporrier, Karine
    Galais, Marie-Pierre
    Clabaut, Tifenn
    Bignon, Anne-Laure
    Parzy, Aurelie
    Gangloff, Alice
    Schwarz, Lilian
    Leveque, Emilie
    Sabourin, Jean-Christophe
    Michel, Pierre
    Vasseur, Nasrin
    Sefrioui, David
    Gilibert, Andre
    Di Fiore, Frederic
    BRITISH JOURNAL OF CANCER, 2025,
  • [28] First-line targeted therapies in the treatment of metastatic colorectal cancer - role of cetuximab
    Tonini, Giuseppe
    Calvieri, Alice
    Vincenzi, Bruno
    Santini, Daniele
    ONCOTARGETS AND THERAPY, 2009, 2 : 73 - 82
  • [29] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2012, 17 (04): : 513 - 524
  • [30] Capecitabine and bevacizumab as first-line treatment in elderly patients with metastatic colorectal cancer
    J Feliu
    M J Safont
    A Salud
    F Losa
    C García-Girón
    C Bosch
    P Escudero
    R López
    C Madroñal
    M Bolaños
    M Gil
    A Llombart
    J Castro-Carpeño
    M González-Barón
    British Journal of Cancer, 2010, 102 : 1468 - 1473
12345